GlassScriptPhysician profile
Nathan S Trookman
NPI 1679669568
$10,882.76
in general payments reported to CMS, 2019-2025
28 companies · $1,017 in 2025
The $1,017 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,932 · 2020: $122 · 2021: $304 · 2022: $614 · 2023: $630 · 2024: $6,264 · 2025: $1,017.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,000 · Food and Beverage: $2,911.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,000.00 |
| Food and Beverage | $2,910.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $6,651.72 | 2019-2025 | Rinvoq, Botox, Alloderm |
| Galderma Laboratories, L.P. | $874.18 | 2019-2025 | Nemluvio, Aklief |
| Allergan, INC. | $340.39 | 2019-2022 | |
| Almirall LLC | $315.90 | 2019-2021 | |
| Ucb, INC. | $284.61 | 2019-2025 | Bimzelx |
| Novartis Pharmaceuticals Corporation | $263.99 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $243.72 | 2019-2025 | Dupixent, Libtayo |
| Incyte Corporation | $224.86 | 2021-2025 | Opzelura |
| Sun Pharmaceutical Industries INC. | $215.77 | 2019-2024 | Odomzo, Blu-U, Ilumya |
| Janssen Biotech, INC. | $210.75 | 2019-2020 | |
| Amgen INC. | $203.76 | 2019-2024 | Otezla |
| Genzyme Corporation | $189.50 | 2019-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $141.24 | 2019-2024 | Siliq |
| Genentech USA, INC. | $124.50 | 2019 | |
| Lilly USA, LLC | $123.21 | 2019-2024 | Taltz, Ebglyss |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $114.27 | 2019-2025 | |
| Arcutis Biotherapeutics, INC. | $67.16 | 2023-2025 | Zoryve |
| Merz North America, INC. | $44.38 | 2019 | |
| Journey Medical Corporation | $41.59 | 2019-2023 | |
| Solta Medical, A Division of Bausch Health US, LLC | $41.52 | 2025 | |
| Celgene Corporation | $35.13 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $27.78 | 2022 | |
| Leo Pharma INC. | $24.68 | 2024 | Adbry |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.49 | 2022 | |
| Epi Health, LLC | $17.67 | 2019 | |
| Dermira, INC. | $14.92 | 2019 | |
| Aclaris Therapeutics, INC. | $12.40 | 2019 | |
| Prugen, INC. Pharmaceuticals | $10.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Trookman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.